Matches in Wikidata for { <http://www.wikidata.org/entity/Q58814506> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q58814506 description "article scientifique publié en 2014" @default.
- Q58814506 description "artículu científicu espublizáu en febreru de 2014" @default.
- Q58814506 description "im Februar 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58814506 description "scientific article published on 17 February 2014" @default.
- Q58814506 description "wetenschappelijk artikel" @default.
- Q58814506 description "наукова стаття, опублікована в лютому 2014" @default.
- Q58814506 name "Barberry Treatment Reduces Serum Anti-Heat Shock Protein 27 and 60 Antibody Titres and High-sensitivity C-reactive Protein in Patients with Metabolic Syndrome: A Double-blind, Randomized Placebo-controlled Trial" @default.
- Q58814506 name "Barberry Treatment Reduces Serum Anti-Heat Shock Protein 27 and 60 Antibody Titres and High-sensitivity C-reactive Protein in Patients with Metabolic Syndrome: A Double-blind, Randomized Placebo-controlled Trial" @default.
- Q58814506 type Item @default.
- Q58814506 label "Barberry Treatment Reduces Serum Anti-Heat Shock Protein 27 and 60 Antibody Titres and High-sensitivity C-reactive Protein in Patients with Metabolic Syndrome: A Double-blind, Randomized Placebo-controlled Trial" @default.
- Q58814506 label "Barberry Treatment Reduces Serum Anti-Heat Shock Protein 27 and 60 Antibody Titres and High-sensitivity C-reactive Protein in Patients with Metabolic Syndrome: A Double-blind, Randomized Placebo-controlled Trial" @default.
- Q58814506 prefLabel "Barberry Treatment Reduces Serum Anti-Heat Shock Protein 27 and 60 Antibody Titres and High-sensitivity C-reactive Protein in Patients with Metabolic Syndrome: A Double-blind, Randomized Placebo-controlled Trial" @default.
- Q58814506 prefLabel "Barberry Treatment Reduces Serum Anti-Heat Shock Protein 27 and 60 Antibody Titres and High-sensitivity C-reactive Protein in Patients with Metabolic Syndrome: A Double-blind, Randomized Placebo-controlled Trial" @default.
- Q58814506 P1433 Q58814506-AEA5F616-D844-465D-9CBE-32DF8171DEBA @default.
- Q58814506 P1476 Q58814506-408F522B-0D90-4D60-BA29-2F3840BA1765 @default.
- Q58814506 P2093 Q58814506-470068CB-4668-489D-AA68-0D635A82A6E8 @default.
- Q58814506 P2093 Q58814506-977E0149-20B6-420C-8BB1-8433733F6608 @default.
- Q58814506 P2093 Q58814506-D42F47CF-416A-4CEC-AA89-B6FB7EC16826 @default.
- Q58814506 P2093 Q58814506-D6498382-CB19-4E87-A2DE-4366F30EBE21 @default.
- Q58814506 P2093 Q58814506-E611ACFF-EA86-4334-8E9F-CDA26B98D31C @default.
- Q58814506 P2860 Q58814506-0C812F7C-514F-4717-AB5B-C103BBA65DC7 @default.
- Q58814506 P2860 Q58814506-2500B855-2A9B-4807-8903-C4609ED260B3 @default.
- Q58814506 P2860 Q58814506-2E6B8F68-1417-4B97-9C97-9F3E0565F625 @default.
- Q58814506 P2860 Q58814506-51CF9D9A-AD86-45CE-B6F6-9DA0809CA595 @default.
- Q58814506 P2860 Q58814506-641A09F5-6F74-4E82-8D0E-755D52938965 @default.
- Q58814506 P2860 Q58814506-685227D2-FC5A-4665-A812-D7BF04EB6D56 @default.
- Q58814506 P2860 Q58814506-E81FFA51-1E19-4491-9A62-974A4BA134DB @default.
- Q58814506 P304 Q58814506-759234C2-5E3E-4DA4-BECA-04C5DBCA27F7 @default.
- Q58814506 P31 Q58814506-342C0A72-0A3D-4727-8877-C38B3114483A @default.
- Q58814506 P356 Q58814506-521D4CB2-08B0-41FC-920B-652FE86A3375 @default.
- Q58814506 P433 Q58814506-B46E6AAB-431A-489C-9F15-E2FA70CDF3F5 @default.
- Q58814506 P478 Q58814506-9E270498-6562-4A23-8327-47CFEB9E0943 @default.
- Q58814506 P50 Q58814506-C18A7E83-7A3C-4987-A5A6-EB0B1E817E29 @default.
- Q58814506 P577 Q58814506-6DB3825D-5D56-4BC0-86B7-17B1A94CF1FB @default.
- Q58814506 P698 Q58814506-49B30B38-E54D-42AD-8AA9-88AEB28B4BCC @default.
- Q58814506 P921 Q58814506-2F17DCEA-9536-401D-A227-D37721BF78C7 @default.
- Q58814506 P921 Q58814506-6EA2F343-2E96-48DD-9829-94C338381D60 @default.
- Q58814506 P921 Q58814506-ABD986F1-B867-4D6C-87D5-C07A7D49EC47 @default.
- Q58814506 P921 Q58814506-FCB62B83-6097-4A67-91B4-502EA0E24DF5 @default.
- Q58814506 P356 PTR.5117 @default.
- Q58814506 P698 24536039 @default.
- Q58814506 P1433 Q7189844 @default.
- Q58814506 P1476 "Barberry treatment reduces serum anti-heat shock protein 27 and 60 antibody titres and high-sensitivity c-reactive protein in patients with metabolic syndrome: a double-blind, randomized placebo-controlled trial" @default.
- Q58814506 P2093 "Gordon A A Ferns" @default.
- Q58814506 P2093 "Majid Ghayour-Mobarhan" @default.
- Q58814506 P2093 "Marzie Zilaee" @default.
- Q58814506 P2093 "Shima Tavalaee" @default.
- Q58814506 P2093 "Tayyebeh Kermany" @default.
- Q58814506 P2860 Q30366941 @default.
- Q58814506 P2860 Q34594086 @default.
- Q58814506 P2860 Q34960748 @default.
- Q58814506 P2860 Q35781478 @default.
- Q58814506 P2860 Q36502707 @default.
- Q58814506 P2860 Q37649608 @default.
- Q58814506 P2860 Q46519641 @default.
- Q58814506 P304 "1211-1215" @default.
- Q58814506 P31 Q13442814 @default.
- Q58814506 P356 "10.1002/PTR.5117" @default.
- Q58814506 P433 "8" @default.
- Q58814506 P478 "28" @default.
- Q58814506 P50 Q41667077 @default.
- Q58814506 P577 "2014-02-17T00:00:00Z" @default.
- Q58814506 P698 "24536039" @default.
- Q58814506 P921 Q108853737 @default.
- Q58814506 P921 Q128406 @default.
- Q58814506 P921 Q269829 @default.
- Q58814506 P921 Q657193 @default.